Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence.

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

December 25, 2023

Study Completion Date

December 25, 2023

Conditions

Thromboembolism

Interventions

DEVICE

ReX-C intervention

Patients receive medication by the ReX-C device

OTHER

Standard of Care

Patients receive medication as usual

Trial Locations (1)

RECRUITING

Carmel Medical Center, Haifa

All Listed Sponsors

lead

Dosentrx Ltd.

INDUSTRY

NCT03424330 - Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence. | Biotech Hunter | Biotech Hunter